AstraZeneca drug wins EU approval for depression use

AstraZeneca PLC says its schizophrenia drug Seroquel XR has been recommended by European regulators as an add-on treatment for depression.

Read the rest here:
AstraZeneca drug wins EU approval for depression use

Related posts:

1. Astra drug wins EU approval for depression use
2. Clinical Data gets approval of depression drug
3. Depression Drug Results Disappoint Targacept and AstraZeneca
4. AstraZeneca, Targacept drug fails depression test
5. Approval Junkies: stop needing the approval of others for happier living!